A phase II study of alprostadil for the treatment of Raynaud's phenomenon
Phase of Trial: Phase II
Latest Information Update: 06 Jan 2016
At a glance
- Drugs Alprostadil (Primary)
- Indications Raynaud's disease
- Focus Therapeutic Use
- 06 Jan 2016 Planned initiation date changed from 1 Jan 2016 to 1 Jul 2016, as per Apricus Biosciences media release.
- 05 Nov 2015 According to an Apricus Biosciences media release, this study is expected to start in the second half of 2016.
- 21 Sep 2015 New trial record